Novel risk scoring system for immune checkpoint inhibitors treatment in non-small cell lung cancer.
Li C, Shi M, Lin X, Zhang Y, Yu S, Zhou C, Yang N, Zhang J, Zhang F, Lv T, Liu H, Song Y.
Li C, et al. Among authors: zhang f, zhang j, zhang y.
Transl Lung Cancer Res. 2021 Feb;10(2):776-789. doi: 10.21037/tlcr-20-832.
Transl Lung Cancer Res. 2021.
PMID: 33718021
Free PMC article.